Vugt, H. van(Hennie van Vugt)
ﬂuenza virus vaccination vaccine person titer ﬂuenza virus vaccination ﬂuenza virus vaccine response antibody study ﬁ rst vaccination hi titer pandemic effect group 7 months hi titers signi health care workers 2010. h 1n 2009 difference vaccinated ﬁ nal model ﬁcant 59-adjuvanted strain netherland ﬁ rst ﬂuenza vaccine antibody response monovalent mf 59-adjuvanted ﬂuenza virus vaccines baseline serum 2009. ﬁ rst dose history h 1n viruses immunogenicity 2011. month 60 years antibody titers disease value adult monovalent 137 persons serum sample model trivalent sample infection hospital erasmu interaction health 2009. mf 59-adjuvanted 2009 vaccine vaccine immunol immunity 50 years participant hi antibody response cross-reactive antibodies women signi ﬁcant increase table elisabeth hospital ﬂuenza vaccines downloaded library assay 3 weeks h 1n virus humoral immunity ﬂuenza virus variable
1 Most Recent Publications
Immunogenicity, boostability, and sustainability of the immune response after vaccination against influenza A virus (H1N1) 2009 in a healthy population
Huijskens, E. Rossen, J. Mulder, P. Beek, R. van Vugt, H. van Verbakel, J. Rimmelzwaan, G.F. Koopmans, M. Peeters, M.